Korean J Gastrointest Endosc.  2006 Nov;33(5):322-325.

Percutaneous Transhepatic Gallbladder Stenting for Acute Cholecystitis after Palliative Metallic Biliary Stenting

Affiliations
  • 1Department of Internal Medicine, Pusan National University College of Medicine, Busan, Korea. hero0791@paran.com

Abstract

Metallic biliary stenting to relieve a malignant biliary obstruction can cause a cystic duct obstruction and acute cholecystitis. Percutaneous transhepatic cholecystostomy is often performed in patients with a limited life expectancy but can have a significant impact on the quality of life. Percutaneous transhepatic gallbladder stenting (PTGS) was performed across the cystic duct via the cholecystostomy tube tract to allow the removal of the cholecystostomy tube. The patient remained asymptomatic for 7 months after PTGS. In conclusion, PTGS across the cystic duct may be considered a treatment option in selected patients who develop acute cholecystitis after palliative metallic biliary stenting.

Keyword

Percutaneous transhepatic gallbladder stenting; Acute cholecystitis

MeSH Terms

Cholecystitis, Acute*
Cholecystostomy
Cystic Duct
Gallbladder*
Humans
Life Expectancy
Quality of Life
Stents*
Full Text Links
  • KJGE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr